Clinical Trial

Retrograde Intrarenal Surgery Low Risk Trial

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
In the treatment of kidney stones and upper ureteral stones, flexible ureteroscopic lithotripsy has become the mainstream choice due to its minimally invasive nature and high safety. However, there is still no universal consensus on the use of prophylactic antibiotics before surgery. Taiwan, located in the subtropical region, is one of the areas in the world with a high incidence of urinary tract stones. Currently, there are no established guidelines for the use of prophylactic antibiotics before flexible ureteroscopic lithotripsy in Taiwan. This study aims to evaluate the differences between single-dose, different types of prophylactic antibiotics in generally healthy adult patients undergoing flexible ureteroscopic lithotripsy.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT06741917
Lead Sponsor National Taiwan University Hospital
Conditions Retrograde Intrarenal Surgery, Renal Stones
Enrollment 200 participants
Start Date 2024-12-04
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-19